Cytovation As
Clinical trials sponsored by Cytovation As, explained in plain language.
-
New combo therapy targets Hard-to-Treat cancers
Disease control CompletedThis early-stage trial tested a new drug called CyPep-1, injected directly into tumors, combined with the immunotherapy pembrolizumab. It included 6 adults with advanced head and neck cancer, melanoma, or triple-negative breast cancer that had spread. The goal was to see if the c…
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New injection targets tumors directly in advanced cancer trial
Disease control CompletedThis early-phase trial tested an experimental drug called CyPep-1, injected directly into tumors, either alone or with the immunotherapy pembrolizumab. The study included 60 adults with advanced solid cancers that had stopped responding to standard treatments. The main goals were…
Phase: PHASE1, PHASE2 • Sponsor: Cytovation AS • Aim: Disease control
Last updated May 15, 2026 11:54 UTC